Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Generative models focused on multifactorial causal mechanisms in brain disorders are scarce and generally based on limited data. Despite the biological importance of the multiple interacting processes, their effects remain poorly characterized from an integrative analytic perspective. Here, we propose a spatiotemporal multifactorial causal model (MCM) of brain (dis)organization and therapeutic intervention that accounts for local causal interactions, effects propagation via physical brain networks, cognitive alterations, and identification of optimum therapeutic interventions. In this article, we focus on describing the model and applying it at the population‐based level for studying late onset Alzheimer’s disease (LOAD). By interrelating six different neuroimaging modalities and cognitive measurements, this model accurately predicts spatiotemporal alterations in brain amyloid‐&bgr; (A&bgr;) burden, glucose metabolism, vascular flow, resting state functional activity, structural properties, and cognitive integrity. The results suggest that a vascular dysregulation may be the most‐likely initial pathologic event leading to LOAD. Nevertheless, they also suggest that LOAD it is not caused by a unique dominant biological factor (e.g. vascular or A&bgr;) but by the complex interplay among multiple relevant direct interactions. Furthermore, using theoretical control analysis of the identified population‐based multifactorial causal network, we show the crucial advantage of using combinatorial over single‐target treatments, explain why one‐target A&bgr; based therapies might fail to improve clinical outcomes, and propose an efficiency ranking of possible LOAD interventions. Although still requiring further validation at the individual level, this work presents the first analytic framework for dynamic multifactorial brain (dis)organization that may explain both the pathologic evolution of progressive neurological disorders and operationalize the influence of multiple interventional strategies. Graphical abstract Symbol Symbol. No Caption available. HighlightsA multifactorial causal model (MCM) of brain (dis)organization and therapeutic intervention is proposed.Prediction of complex multifactorial alterations in Alzheimer’s disease, using six different neuroimaging modalities and the MCM.Identification of potential triggering pathological events and associated “epicenter” brain regions.Identification and characterization of direct multifactorial interactions, vulnerability, and influence level of each biological factor.Identification of optimum therapeutic strategies to stop/reverse disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Complex network measures of brain connectivity: Uses and interpretations
Rubinov, M., & Sporns, O. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.10.003 · Cited by 11,522
A fast diffeomorphic image registration algorithm
Ashburner, J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.007 · Cited by 8,122
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731 · cited 1×
“All images underwent non-uniformity correction using the N3 algorithm (Sled et al., 1998).”
Self-citationJack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
DPARSF: a MATLAB toolbox for “pipeline” data analysis of resting-state fMRI
Yan (2010) · Frontiers in System Neuroscience · doi:10.3389/fnsys.2010.00013 · Cited by 3,475 · cited 1×
“…slice timing correction, 3) spatial normalization to MNI space (Evans et al., 1994) using the registration parameters obtained for the structural T1 image with the nearest acquisition date, and 4) signal filtering to keep only low frequency fluctuations (0.01–0.08 Hz) (ChaoGan and Yu-Feng, 2010).”
InfluentialExploring the brain network: A review on resting-state fMRI functional connectivity
van den Heuvel, M. P., & Hulshoff Pol, H. E. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.03.008 · Cited by 3,326
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Buckner, R. L., Sepulcre, J., Talukdar, T., Krienen, F. M., Liu, H., Hedden, T., Andrews-Hanna, J. R., Sperling, R. A., & Johnson, K. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5062-08.2009 · Cited by 2,862
Regional homogeneity approach to fMRI data analysis.
Zang, Y., Jiang, T., Lu, Y., He, Y., & Tian, L. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.12.030 · Cited by 2,614 · cited 1×
“Our causal analysis suggests that an initial vascular disequilibrium in specific brain areas (e.g. hippocampus and entorhinal regions) may be the most-likely event triggering LOAD progression (Iadecola, 2004; Zlokovic, 2011).”
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Inferring Regulatory Networks from Expression Data Using Tree-Based Methods
Huynh-Thu, V. A., Irrthum, A., Wehenkel, L., & Geurts, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012776 · Cited by 2,131
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960 · cited 2×
“S1), which might explain why recent one-target Aβ based therapies have failed to improve clinical outcomes in LOAD (Doody et al., 2014; Salloway et al., 2014).”
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668 · cited 2×
“It also provides an efficiency ranking of multiple possible LOAD interventions, which might explain why recent one-target Aβ based therapies failed to improve clinical outcomes in LOAD (Doody et al., 2014; Salloway et al., 2014).”
Sugar for the brain: the role of glucose in physiological and pathological brain function
Mergenthaler, P., Lindauer, U., Dienel, G. A., & Meisel, A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.07.001 · Cited by 1,612 · cited 3×
“Glucose metabolic impairment and structural degeneration presented high interregional propagation effects, with CSD (Chang et al., 2013; Mergenthaler et al., 2013) and axonal degeneration (Lingor et al., 2012) being potential underlying mechanisms, respectively.”
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202
Self-citationWhole-brain anatomical networks: does the choice of nodes matter?
Zalesky, A., Fornito, A., Harding, I. H., Cocchi, L., Yücel, M., Pantelis, C., & Bullmore, E. T. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.027 · Cited by 1,169
The hubs of the human connectome are generally implicated in the anatomy of brain disorders
Crossley, N. A., Mechelli, A., Scott, J., Carletti, F., Fox, P. T., McGuire, P., & Bullmore, E. T. (2014) · Brain · doi:10.1093/brain/awu132 · Cited by 1,166
Neuronal activity enhances tau propagation and tau pathology in vivo
Wu, J. W., Hussaini, S. A., Bastille, I. M., Rodriguez, G. A., Mrejeru, A., Rilett, K., Sanders, D. W., Cook, C., Fu, H., Boonen, R. A. C. M., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4328 · Cited by 820
Ten simple rules for dynamic causal modeling
Stephan, K. E., Penny, W. D., Moran, R. J., den Ouden, H. E. M., Daunizeau, J., & Friston, K. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.015 · Cited by 803 · cited 1×
“Similarly to previous causal models (Friston et al., 2014; Stephan et al., 2010; Valdes-sosa et al., 2011b), but now going beyond the unifactor interaction/spreading, the MCM equations describe: (i) how the present state of a given biological factor, at a given brain region, causes new fluctuations in other factors or…”
Prion-like transmission of protein aggregates in neurodegenerative diseases
Brundin, P., Melki, R., & Kopito, R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2873 · Cited by 778
Prion-like mechanisms in neurodegenerative diseases
Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776 · cited 2×
“However, our results (Figures 6c) suggest that, in addition to the conventional functional and Aß changes propagation (Brundin et al., 2010; de Haan et al., 2012; Frost and Diamond, 2010), other biological factors may propagate their pathologic effects also to distant brain regions.”
Khan, U. A., Liu, L., Provenzano, F. A., Berman, D. E., Profaci, C. P., Sloan, R., Mayeux, R., Duff, K. E., & Small, S. A. (2014) · Nature Neuroscience · doi:10.1038/nn.3606 · Cited by 561
Friston, K. J., Kahan, J., Biswal, B., & Razi, A. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.12.009 · Cited by 553 · cited 3×
“In addition to factor-factor interactions, the propagation of factorspecific alterations is thought to be a relevant mechanism on disease progression (Cabral et al., 2012; Friston et al., 2014; Iturria-Medina et al., 2014; Iturria-Medina and Evans, 2015; Sanz Leon et al., 2013).”
The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease
Braak, H., & Del Tredici, K. (2015) · Brain · doi:10.1093/brain/awv236 · Cited by 540
Networks of anatomical covariance
Evans, A. C. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.054 · Cited by 429 · cited 1×
“…to the statistical nature of the GENIE3 algorithm, the obtained vascular networks would be reflecting covariance patterns among the regions, similarly to functional and structural networks created via association techniques (Evans, 2013; Monti et al., 2014; van den Heuvel and Hulshoff Pol, 2010).”
Self-citationMathematical framework for large-scale brain network modeling in The Virtual Brain
Sanz-Leon, P., Knock, S. A., Spiegler, A., & Jirsa, V. K. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.01.002 · Cited by 356 · cited 1×
“…to take action locally and spread through anatomical connections (Cabral et al., 2012; Friston et al., 2014; Iturria-Medina et al., 2014; Mišić et al., 2015; Raj et al., 2012; Sanz Leon et al., 2013; Sanz-Leon et al., 2015; Sotero et al., 2007; Stam et al., 2016; Valdes-sosa et al., 2011a).”
Neurovascular signalling defects in neurodegeneration
Zacchigna, S., Lambrechts, D., & Carmeliet, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2336 · Cited by 345
Cooperative and competitive spreading dynamics on the human connectome
Mišić, B., Betzel, R. F., Nematzadeh, A., Goñi, J., Griffa, A., Hagmann, P., Flammini, A., Ahn, Y.-Y., & Sporns, O. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.035 · Cited by 342
Šišková, Z., Justus, D., Kaneko, H., Friedrichs, D., Henneberg, N., Beutel, T., Pitsch, J., Schoch, S., Becker, A., von der Kammer, H., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.024 · Cited by 320 · cited 4×
“As mentioned, the direct coupling among multiple biological factors is a key feature of the brain, both in health and disease (Andreone et al., 2015; Bero et al., 2011; Iturria-Medina and Evans, 2015; Qosa et al., 2014; Readnower et al., 2011; Šišková et al., 2014).”
InfluentialA data-driven model of biomarker changes in sporadic Alzheimer’s disease
Young, A. L., Oxtoby, N. P., Daga, P., Cash, D. M., Fox, N. C., Ourselin, S., Schott, J. M., & Alexander, D. C. (2014) · Brain · doi:10.1093/brain/awu176 · Cited by 308
Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
Meyer, E. P., Ulmann-Schuler, A., Staufenbiel, M., & Krucker, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709788105 · Cited by 260 · cited 9×
“An interesting example is the futile increase in CBF that a glucose metabolic dysfunction may induce.”
InfluentialNeuronal and vascular interactions
Andreone, B. J., Lacoste, B., & Gu, C. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033835 · Cited by 256 · cited 2×
“As mentioned, the direct coupling among multiple biological factors is a key feature of the brain, both in health and disease (Andreone et al., 2015; Bero et al., 2011; Iturria-Medina and Evans, 2015; Qosa et al., 2014; Readnower et al., 2011; Šišková et al., 2014).”
Optimally controlling the human connectome: the role of network topology
Betzel, R. F., Gu, S., Medaglia, J. D., Pasqualetti, F., & Bassett, D. S. (2016) · Scientific Reports · doi:10.1038/srep30770 · Cited by 247
Estimating long‐term multivariate progression from short‐term data
Donohue, M. C., Jacqmin‐Gadda, H., Le Goff, M., Thomas, R. G., Raman, R., Gamst, A. C., Beckett, L. A., Jack, C. R., Weiner, M. W., Dartigues, J., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.10.003 · Cited by 197 · cited 2×
“, 2010) and data-driven (Donohue et al., 2014; Dukart et al., 2013; Fonteijn et al., 2012; Iturria-Medina et al., 2016; Young et al., 2014) models that define a multifactorial LOAD pathogenesis are invariably based on the magnitude”
Modeling the outcome of structural disconnection on resting-state functional connectivity
Cabral, J., Hugues, E., Kringelbach, M. L., & Deco, G. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.007 · Cited by 182
Qosa, H., Abuasal, B. S., Romero, I. A., Weksler, B., Couraud, P.-O., Keller, J. N., & Kaddoumi, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.023 · Cited by 146 · cited 5×
“For example, a vascular alteration should propagate mostly, if not entirely, by the brain’s vascular network, while the Aß proteins may propagate through both the anatomical and the vascular networks (Iturria-Medina et al., 2014; Qosa et al., 2014).”
InfluentialAxonal degeneration as a therapeutic target in the CNS
Lingor, P., Koch, J. C., Tönges, L., & Bähr, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1362-3 · Cited by 119 · cited 2×
“, 2010; Frost and Diamond, 2010) and axonal degeneration effects (Lingor et al., 2012).”
Cited by
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Vogel, J. W., Iturria-Medina, Y., Strandberg, O. T., Smith, R., Levitis, E., Evans, A. C., Hansson, O., Initiative, A. D. N., Weiner, M., Aisen, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15701-2 · Cited by 516
Self-citationVeitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.005 · Cited by 454
Perez Ortiz, J. M., & Swerdlow, R. H. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14585 · Cited by 426
Preventing dementia by preventing stroke: The Berlin Manifesto
Hachinski, V., Einhäupl, K., Ganten, D., Alladi, S., Brayne, C., Stephan, B. C. M., Sweeney, M. D., Zlokovic, B., Iturria‐Medina, Y., Iadecola, C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.001 · Cited by 313
Self-citationMitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
Cenini, G., & Voos, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00902 · Cited by 257
Metadata
- Authors
- Iturria-Medina, Y., Carbonell, F. M., Sotero, R. C., Chouinard-Decorte, F., & Evans, A. C.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 152
- Pages
- 60-77
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2592672814
- Cited by
- 130
- References
- 39
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.